Two of three polio viruses eradicated in 'historic' step: WHO

The World Health Organization welcomed an "historic step" toward a polio-free world on Thursday as an expert panel certified that the second of three types of the crippling virus has been eradicated globally.

Deaths, bad outcomes elude scrutiny at Canada's indigenous clinics

Ina Matawapit was barely conscious - intoxicated and suffering from a blow to the head - when police drove her to the North Caribou Lake clinic in Ontario, Canada, one summer evening in 2012.

Several states wary of $48 billion opioid settlement proposal

Several U.S. states that have been ravaged by the opioid epidemic are pushing back on a proposed $48 billion settlement framework that would resolve thousands of lawsuits against five drug companies accused of fueling the addiction crisis.

High blood pressure meds work better taken at bedtime

(Reuters Health) - When people take their hypertension medications at bedtime, blood pressure is better controlled during the night and the risk of death or illness due to cardiovascular disease is significantly lowered, a new study suggests.

South Korean retailer drops flavored liquid e-cigarettes

South Korea's top convenience store chain suspended the sale of flavored liquid e-cigarettes made by U.S. company Juul Labs on Thursday, a day after the government warned the public to stop using such products citing fatalities in the United States.

New York, states reach $700 million settlement with Reckitt over opioid probes

New York and other states have reached a $700 million settlement deal with Reckitt Benckiser over allegations that the drug distributor improperly marketed a drug to treat opioid addiction, New York Attorney General Letitia James said on Wednesday.

U.S. FDA says carcinogen not found in alternatives of Zantac and its generics

U.S. retailers Walmart Inc, CVS Health Corp Walgreens Boots Alliance Inc and Rite Aid Corp have all removed Zantac off their shelves after some drugs containing its key ingredient ranitidine were found to have traces of the impurity, N-nitrosodimethylamine (NDMA).

Teva’s proposed opioid settlement could cost drugmaker pennies on the dollar

Teva Pharmaceutical Industries Ltd's proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts.

GSK gets FDA nod for wider use of ovarian cancer drug Zejula

GlaxoSmithKline said U.S. regulators had approved its ovarian cancer treatment Zejula for wider use in some advanced cancers, in a boost to the British drugmaker's oncology portfolio as it competes with rival AstraZeneca.

Amazon buys healthcare start-up Health Navigator

Amazon.com Inc said on Wednesday it bought healthcare start-up Health Navigator, its second purchase in the healthcare services industry.

That last toke for the road could be a downer with pot breathalyzers coming

One toke for the road could end up being a total bummer for drivers who smoke pot, with several companies in the United States preparing to market cannabis breathalyzers as legalized marijuana spreads across the country.

Related Videos

Apple to debut a new TV show tackling #MeToo

Hollywood's fastest growing job takes on sex scenes

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS